Sanjay Y. Choudhari
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Systematic Review and Meta-Analysis of Efficacy and Safety of Liraglutide in Patients with Type 2 Diabetes Mellitus.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: September 30, 2025
Correction: Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial.
Journal: Cardiovascular diabetology. Endocrinology reports
Published: September 27, 2025
Effectiveness and Safety of Telmisartan Plus Amlodipine Compared to Telmisartan Plus Cilnidipine in Indian Patients with Hypertension and Renal Impairment: A Randomized, Open Label, Post Marketing Study (START Renal).
Journal: International journal of nephrology and renovascular disease
Published: July 22, 2025
Triple arm, prospective, real-world study comparing the efficacy of FDC teneligliptin + dapagliflozin to FDC sitagliptin + dapagliflozin, and FDC linagliptin + empagliflozin in Indian type 2 diabetes mellitus patients using CGM device: the Amplify-TIR study.
Journal: Cardiovascular diabetology. Endocrinology reports
Published: June 13, 2025
Effect of liraglutide biosimilar vs. reference liraglutide on weight reduction in T2DM patients with obesity: post hoc analysis of phase III trial.
Journal: Cardiovascular diabetology. Endocrinology reports
Published: December 22, 2024
A prospective, multicentre study evaluating safety and efficacy of a fixed dose combination of Remogliflozin etabonate, Vildagliptin, and Metformin in Indian patients with type 2 diabetes mellitus (Triad-RMV).
Journal: Clinical diabetes and endocrinology
Published: September 16, 2024
Patient Profile-Based Management with Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.
Journal: Pulmonary therapy
Published: August 01, 2024
Efficacy and Safety of Pregabalin Prolonged Release-Etoricoxib Combination Compared to Etoricoxib for Chronic Low Back Pain: Phase 3, Randomized Study.
Journal: Pain and therapy
Published: July 14, 2022
Adherence, satisfaction, and experience with metformin 500 mg prolonged release formulation in Indian patients with type 2 diabetes mellitus: a postmarketing observational study.
Journal: International journal of general medicine
Published: May 02, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026